{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:37Z","timestamp":1740108157226,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"EMIF","award":["115372"],"award-info":[{"award-number":["115372"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00127-020-01872-2","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T15:59:11Z","timestamp":1591199951000},"page":"409-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment pathway analysis of newly diagnosed dementia patients in four electronic health record databases in Europe"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-3156","authenticated-orcid":false,"given":"Glen","family":"James","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Collin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Lawrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Podhorna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Zaremba-Pechmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rijnbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"van der Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Avillach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Pasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mees","family":"Mosseveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Grosdidier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Gungabissoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Egger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Celis-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Forrest","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"1872_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington"},{"key":"1872_CR2","unstructured":"Prince M, Wimo A, Guerchet M, Gemma-Claire A, Wu YT, Prina M (2015) World Alzheimer Report 2015: the global impact of dementia\u2014an analysis of prevalence, incidence, cost and trends. https:\/\/www.alz.co.uk\/research\/world-report-2015"},{"issue":"1","key":"1872_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9(1):63\u201375","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1872_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1586\/14737175.7.4.407","volume":"7","author":"KR Scott","year":"2007","unstructured":"Scott KR, Barrett AM (2007) Dementia syndromes: evaluation and treatment. Expert Rev Neurother 7(4):407\u2013422 (NIH Public Access)","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"1872_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpt.946","volume":"103","author":"RA Miksad","year":"2018","unstructured":"Miksad RA, Abernethy AP (2018) Harnessing the power of real-world evidence (RWE): a checklist to ensure regulatory-grade data quality. Clin Pharmacol Ther 103(2):202\u2013205","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1872_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1872_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pds.1335","volume":"16","author":"JD Lewis","year":"2007","unstructured":"Lewis JD, Schninnar R, Bilker WB, Wang X, Strom BL (2007) Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16(4):393\u2013401","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4\u20135","key":"1872_CR8","first-page":"339","volume":"38","author":"AE Vlug","year":"1999","unstructured":"Vlug AE et al (1999) Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 38(4\u20135):339\u2013344","journal-title":"Methods Inf Med"},{"issue":"3","key":"1872_CR9","first-page":"156","volume":"28","author":"L Fabiani","year":"2004","unstructured":"Fabiani L et al (2004) Health Search-Research Institute of the Italian Society of General Practice: the creation of a research database in general practice. Epidemiol Prev 28(3):156\u2013162","journal-title":"Epidemiol Prev"},{"issue":"1","key":"1872_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CLEP.S13458","volume":"2","author":"V Ehrenstein","year":"2010","unstructured":"Ehrenstein V, Antonsen S, Pedersen L (2010) Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2(1):273\u2013279","journal-title":"Clin Epidemiol"},{"issue":"4","key":"1872_CR11","first-page":"251","volume":"19","author":"BT Blak","year":"2011","unstructured":"Blak BT, Thompson M, Dattani H, Bourke A (2011) Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 19(4):251\u2013255","journal-title":"Inform Prim Care"},{"key":"1872_CR12","first-page":"190","volume":"150","author":"P Avillach","year":"2009","unstructured":"Avillach P, Mougin F, Joubert M, Thiessard F (2009) A semantic approach for the homogeneous identification of events in eight patient databases : a contribution to the European eu-ADR Project. Med Inform United Health Eur 150:190\u2013194","journal-title":"Med Inform United Health Eur"},{"issue":"1","key":"1872_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/amiajnl-2012-000933","volume":"20","author":"P Avillach","year":"2013","unstructured":"Avillach P et al (2013) Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. J Am Med Inform Assoc 20(1):184\u2013192","journal-title":"J Am Med Inform Assoc"},{"issue":"12","key":"1872_CR14","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/pds.1829","volume":"18","author":"RH Preciosa","year":"2009","unstructured":"Preciosa RH, Coloma M, Chuemie MJ, Trifiro G, Gini R, van der Lei JL, Hippisley-Cox MSJ, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L (2009) Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 18(12):1150\u20131157","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1872_CR15","doi-asserted-by":"publisher","first-page":"e002862","DOI":"10.1136\/bmjopen-2013-002862","volume":"3","author":"PM Coloma","year":"2013","unstructured":"Coloma PM et al (2013) Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. BMJ Open 3(6):e002862","journal-title":"BMJ Open"},{"key":"1872_CR16","volume-title":"Paris declaration\u2014policy in practice","author":"A Europe","year":"2009","unstructured":"Europe A (2009) Paris declaration\u2014policy in practice. Alzheimer Europe, Luxembourg"},{"key":"1872_CR17","volume-title":"FDA-approved treatments for Alzheimer\u2019s","author":"A. Association","year":"2017","unstructured":"A. Association (2017) FDA-approved treatments for Alzheimer\u2019s. A. Association, Washington"},{"issue":"10113","key":"1872_CR18","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston G et al (2017) Dementia prevention, intervention, and care. Lancet 390(10113):2673\u20132734","journal-title":"Lancet"},{"issue":"2","key":"1872_CR19","doi-asserted-by":"publisher","first-page":"e89216","DOI":"10.1371\/journal.pone.0089216","volume":"9","author":"G Spalletta","year":"2014","unstructured":"Spalletta G et al (2014) Cognitive and affective changes in mild to moderate Alzheimer\u2019s disease patients undergoing switch of cholinesterase inhibitors: A 6-month observational study. PLoS ONE 9(2):e89216","journal-title":"PLoS ONE"},{"issue":"1","key":"1872_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/15622975.2010.538083","volume":"12","author":"R Ihl","year":"2011","unstructured":"Ihl R, Fr\u00f6lich L, Winblad B, Schneider L, Burns A, M\u00f6ller HJ (2011) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer\u2019s disease and other dementias. World J Biol Psychiatry 12(1):2\u201332","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"1872_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/fampra\/20.1.61","volume":"20","author":"H Prosser","year":"2003","unstructured":"Prosser H (2003) Influences on GPs\u2019 decision to prescribe new drugs\u2014the importance of who says what. Fam Pract 20(1):61\u201368","journal-title":"Fam Pract"},{"issue":"1","key":"1872_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/1472-6963-14-469","volume":"14","author":"\u00c1 Lubl\u00f3y","year":"2014","unstructured":"Lubl\u00f3y \u00c1 (2014) Factors affecting the uptake of new medicines: a systematic literature review. BMC Health Ser Res 14(1):469","journal-title":"BMC Health Ser Res"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-020-01872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-020-01872-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-020-01872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T01:07:24Z","timestamp":1622682444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-020-01872-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1007\/s00127-020-01872-2","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"type":"print","value":"0933-7954"},{"type":"electronic","value":"1433-9285"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"22 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"GJ and MA were contractors for GSK at the time of this work. Over the timeframe of this project, MFG was previously employed by Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA and is currently employed by Teva Pharmaceuticals, Inc., Frazer, PA, USA. RS has received research funding within the last five years from Janssen, Roche and GSK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study complies with regulatory requirements regarding patient privacy protection and ethical considerations in the countries in which this study was applied. Data anonymisation procedures were conducted to ensure data were fully anonymised; there was no patient identifiable information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protection of human subjects"}}]}}